ReviewMolecular cancer2018

Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia.

Stefania Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.